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Nuclear receptor SET domain containing protein 2 (NSD2) catalyzes
the methylation of histone H3 lysine 36 (H3K36). It is a deter-
minant in Wolf–Hirschhorn syndrome and is overexpressed in
human multiple myeloma. Despite the relevance of NSD2 to can-
cer, there are no potent, selective inhibitors of this enzyme report-
ed. Here, a combination of kinetic isotope effect measurements
and quantum chemical modeling was used to provide subang-
strom details of the transition state structure for NSD2 enzymatic
activity. Kinetic isotope effects were measured for the methylation
of isolated HeLa cell nucleosomes by NSD2. NSD2 preferentially
catalyzes the dimethylation of H3K36 along with a reduced pref-
erence for H3K36 monomethylation. Primary Me-14C and 36S and
secondary Me-3H3, Me-
2H3, 5′-14C, and 5′-3H2 kinetic isotope ef-
fects were measured for the methylation of H3K36 using specifi-
cally labeled S-adenosyl-L-methionine. The intrinsic kinetic isotope
effects were used as boundary constraints for quantum mechani-
cal calculations for the NSD2 transition state. The experimental
and calculated kinetic isotope effects are consistent with an SN2
chemical mechanism with methyl transfer as the first irreversible
chemical step in the reaction mechanism. The transition state is a
late, asymmetric nucleophilic displacement with bond separation
from the leaving group at (2.53 Å) and bond making to the attack-
ing nucleophile (2.10 Å) advanced at the transition state. The tran-
sition state structure can be represented in a molecular
electrostatic potential map to guide the design of inhibitors that
mimic the transition state geometry and charge.
enzyme mechanism | transition state structure | histone methylation |
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Histone lysine methylation is an essential posttranslationalmodification for transcriptional regulation, DNA damage
response, and chromatin regulation (1, 2). Methyl groups (Me,
CH3) are installed on lysine residues by protein lysine methyl-
transferase enzymes (PKMTs), the majority of which, in humans,
contain a catalytic SET domain (3). The conserved SET do-
main catalyzes the transfer of between one to three CH3 from
S-adenosyl-L-methionine (SAM) onto the e-amino group of lysine
residues (Fig. 1) producing monomethyl, dimethyl, or trimethyl
lysine derivatives (KMe1, KMe2, and KMe3, respectively) (3), in a
reaction that involves first deprotonation of the lysine, and finally
transfer of the methyl group (4, 5).
Histone lysine Me marks can signal either transcriptional ac-
tivation or repression depending on which lysine residue is
methylated and the number of transferred Me groups (2). For
example histone H3 lysine 27 trimethylation is a signal for
transcriptional repression (6), where histone H3 lysine 4 and
histone H3 lysine 36 Me marks are found in actively transcribed
loci (7). As a result, misregulation of PKMT expression is often
associated with cancer development and other disease states (8).
Deletion of the gene encoding the histone H3K36 dimethyl-
transferase enzyme nuclear receptor binding SET domain pro-
tein 2 (NSD2) (also known as WHSC1 or MMSET), specifically,
is present in the developmental disorder Wolf–Hirschhorn syn-
drome (9). By contrast, NSD2 overexpression, as a result of a
t(4;14) chromosomal translocation (10), is manifest in 15% of
multiple myeloma cases and has been identified in other cancers
(11–13). NSD2 catalyzes the monomethylation and dimethyla-
tion of histone H3K36 in vivo (11), although other CH3-transfer
specificities have also been reported in studies using histone
protein or histone tail peptide as substrate analogs (14–16). Studies
using isolated or recombinant nucleosome as physiologically relevant
substrates detected H3K36Me1 and H3K36Me2 as the exclusive
products. Thus, the nature of the substrate can influence NSD2
specificity (11, 17). Substrate specificity is also influenced by the
presence of a C-terminal basic post-SET extension found in NSD
family methyltransferases. NSD2mutants lacking this basic post-SET
extension are unable to recognize nucleosome as substrate (18). The
H3K36Me2 marks introduced by NSD2 are normally concentrated
in the 5′ end of actively transcribed genes (7), and overexpression
results in global increases in H3K36Me2 throughout gene bodies,
resulting in aberrant transcription of multiple oncogenes (11). His-
tone methylation is a reversible posttranslational modification, thus,
inhibiting the catalytic activity of NSD2 is an attractive strategy for
the treatment of multiple myeloma and other cancers.
Designing analogs that mimic the geometry and charge dis-
tribution of the transition state (TS) of enzyme-catalyzed reac-
tions is a powerful approach for enzyme inhibition (19, 20);
however, this requires a detailed model of the enzyme TS. TS
models for a number of PKMT enzymes, including human SET8
(21), and SET7/9 (4, 22), based on quantum mechanical (QM)/
molecular mechanical (MM) calculation of the enzyme
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chemistry, show substantial variability in the predicted TS ge-
ometry of PKMT. However, these models have not been verified
experimentally. Detailed information about TS structure can be
obtained from the measurement of kinetic isotope effects (KIEs)
(23), which result from changes in the bond vibrational envi-
ronment for atoms of the reactants free in solution and at the TS
(23). The measurement of multiple KIEs combined with quan-
tum chemical calculations allow for interrogation of TS structure
(19, 20, 24). Here, we apply this approach for the NSD2-catalyzed
methylation of histone H3K36. Multiple experimental KIEs for
the methylation of HeLa cell nucleosome (HeLaNuc) H3K36 by
the SET domain of NSD2 were measured, and the KIEs were used
to evaluate quantum chemical models of the CH3-transfer TS.
Results and Discussion
NSD2 Dimethylates Histone H3 at Lysine 36 of HeLaNucs. The sub-
strate and product specificity of NSD2 is dependent on both the
nature of the substrate and the NSD2 construct used (17, 18).
We analyzed the product distribution using extracted HeLaNuc
as a mimic of the native substrate and a NSD2 construct con-
taining the C-terminal SET domain and basic post-SET exten-
sions (residues 980–1365). HeLaNuc contain a heterogeneous
mixture of preexisting methyl marks (25). The installation of new
methyl marks was tracked using [Me-2H3]SAM and the products
monitored by liquid chromatography–mass spectrometry (LC-MS)
after protease digestion (Fig. 1). Under these conditions, we ob-
served only monomethylation and dimethylation of histone H3K36
regardless of the preexisting methylation state in the parent nu-
cleosome, consistent with previous reports of wild-type NSD2
specificity (Fig. S1) (11, 17). We also observed no trimethylated
H3K36, consistent with reports that SETD2 is the only known
human H3 K36 trimethyltransferase (26). These results indicate the
specificity of our NSD2 construct was not altered by truncation of
the N-terminal domains. These results indicate that the N-terminal
domains of NSD2 do not directly affect the enzyme chemistry and,
likely, do not affect the TS structure.
Measurement of Intrinsic KIEs and Forward Commitment. KIEs for
methylation of HeLaNuc histone H3K36 by NSD2 were mea-
sured using a competitive radiolabel approach. Under these
conditions, the observed KIEs on Vmax/KM (V/K) include con-
tributions from all isotopically sensitive steps up to and including
the first irreversible reaction, which for PKMT is generally accepted
to be CH3-transfer (5). Thus, any events preceding CH3-transfer,
including substrate binding and lysine deprotonation, can lead to an
observed forward commitment (Cf), which would lower the mag-
nitude of measured KIEs. Cf is a measure of the distribution of
enzyme-bound substrate that proceeds to form product rather than
equilibrate with free substrate. Using the isotope-trapping method
(27), we measured a Cf of 0.087 ± 0.003 for the reaction of SAM
with NSD2SET (Fig. 2A). This Cf is relatively low, indicating that
events preceding CH3-transfer are not significantly rate limiting,
and Eq. 1 can be used to obtain intrinsic KIEs (k) required for TS
analysis, where (V/K) is the observed KIE:
ðV=KÞ= k+Cf

1+Cf

. [1]
Isotopically-labeled SAM for KIE measurements were prepared
enzymatically from appropriately labeled ATP or methionine
precursors (Table S1). KIEs measured for the atomic positions
surrounding the methyl-transfer reaction coordinate are summa-
rized in Table S2 and Fig. 2B. Each KIE was determined under
competitive conditions using a “heavy” substrate, bearing a 3H or
14C at the position of interest, and a “light” substrate with a
remote radiolabel reporting on the corresponding light isotope
at the position of interest. For Me-2H3 and
36S, the heavy sub-
strates also contained a remote 1′-3H or 8-14C label. KIEs were
determined from the change of isotope ratio of the unreacted SAM
after 15–45% had been consumed. Correcting for Cf gave an in-
trinsic primary Me-14C KIE of 1.113 ± 0.006, primary 36S KIE of
1.018 ± 0.008, and secondary Me-3H3, 5′-14C, and 5′-3H2 KIEs of
0.77 ± 0.03, 1.00 ± 0.01, and 1.05 ± 0.01, respectively.
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Fig. 1. NSD2-catalyzed methylation of histone H3 lysine 36 (H3K36).
(A) The general reaction catalyzed by NSD2 showing both mono-
methylation and dimethylation of H3K36. (B) Product distribution for
methylation of HeLaNuc with [Me-2H3]SAM. Products are shown for the
histone H3 (K27–R40) peptide resulting from Arg-C digestion. NSD2
displays a preference for dimethylation H3K36.
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Fig. 2. Determination of intrinsic KIEs and correction for forward commit-
ment factor (Cf). (A) Measurement of Cf by isotope trapping for the meth-
ylation of HeLaNuc H3K36 by NSD2. (B) Intrinsic KIE values by atom position
after correction for Cf. Errors are reported as the SD of at least six replicates
from two independent experiments.
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A large primary 14C KIE is consistent with an SN2 mechanism
where the CH3-transfer is largely rate limiting. The magnitude of
the primary KIE of the transferring methyl group for SN2 reaction
mechanisms is proportional to the symmetry of the TS structure,
with the largest isotope effects expected when bond order to the
nucleophile and leaving group are equal (28). A large inverse
α-secondary 3H KIE for the methyl group hydrogen of 0.77 ± 0.03
suggests the hydrogen vibrational modes are constrained at the TS
relative to the ground state. To confirm the magnitude of this
isotope effect, we also measured the α-secondary Me-2H3 KIE.
The intrinsic Me-2H3 KIE of 0.833 ± 0.007 is in good agreement
with the Me-3H3 isotope effect given the difference in the reduced
mass of each isotope (29). Such large inverse α-secondary KIEs
have previously been observed for the methylation of catechol
substrates by catechol O-methyltransferase (COMT) (30, 31). In
that case, the large inverse KIE was attributed to compression of
the methyl donor–acceptor distance at the TS (30). However, QM/
MM calculations suggest that such compression is not required to
explain the observed inverse KIEs (32, 33).
Computational Models of the NSD2 TS. The TS structure for
methylation of H3K36 by NSD2 was modeled using the intrinsic
KIEs as constraints. The reactant-state input for TS analysis was
derived from the conformation of SAM in the crystal structure
of NSD1 [Protein Data Bank (PDB) ID code 3OOI] (34), as no
structure of NSD2 was available. The catalytic SET domain of
NSD1 and NSD2 are highly homologous containing 79% se-
quence identity. To model the lysine position, the SET domain of
NSD1 was overlaid with those of SET7/9, SET8, and PIM5
bound to their corresponding peptide substrates (Fig. 3A and
Fig. S2) (35–37). The average lysine geometry was used to gen-
erate a simplified TS model (TS1 in Fig. 3B).
The TS geometry for NSD2 can be described by a combination
of the C–N and C–S distances, d1 and d2, shown in Fig. 3B. A
series of TS structures with fixed d1 and d2 distances were cal-
culated at the m062x/6-31G* level of theory, as implemented in
Gaussian 09 (38). No other constraints on the TS geometry or
the S–C–N bond angle were imposed. Theoretical isotope effects
for each geometry were predicted from the scaled vibrational
frequencies using the program ISOEFF98 (Fig. 3C and Fig. S3)
(39). Because NSD2 catalyzes both the monomethylation and
dimethylation of H3K36, the observed KIEs could arise from the
TS for either the first or second methylation reaction or a
combination of the two. The same calculations were performed
using a TS model for the second methylation reaction (Fig. S4).
TS models for both the first and second methylation reaction
catalyzed by NSD2 had highly similar predicted KIEs for all
geometries tested, so for the sake of simplicity we will focus our
discussion on the TS for the first methylation. In general, the
predicted Me-14C KIEs were larger (>1.12) for TS geometries
with more symmetrical bond order to both the sulfur leaving
group and nitrogen nucleophile, with a later, asymmetric TS
matching the observed KIE of 1.113 (Fig. 3C). A number of TS
geometries with compressed donor–acceptor distances predict
inverse Me-3H3 KIEs but gave poor agreement with the Me-
14C
KIE. Instead, the predicted Me-3H3 KIEs matched most opti-
mally to TS geometries with greater bond order to the lysine
nitrogen. Predicted 36S KIEs are also consistent for a product-
like TS geometry with substantial loss of bond order to the
transferring CH3 group at the TS. The closest match to all in-
trinsic KIEs was observed with d1 and d2 fixed at 1.8 and 2.6 Å,
respectively, corresponding to a late product-like TS geometry;
however, no TS geometry was able to reproduce the observed 5′-3H2
KIE (Figs. S3 and S4). This KIE is highly dependent on the bound
SAM geometry and was found to vary substantially as the result of
rotation around the C5′–S bond in our simplified TS model (Fig. S5).
Previous work indicates QM tunneling can contribute to the
magnitude of heavy-atom KIEs (40, 41). To assess the possibility
that QM tunneling contributes to our observed Me-14C KIE, we
calculated predicted Me-14C KIEs while including a correction
for carbon tunneling. For our system, the magnitude of predicted
KIEs including tunneling are larger than the intrinsic value for
all TS geometries tested (Fig. S6), and, as a result, we did not
include a tunneling correction in our final TS predictions.
Secondary hydrogen KIEs can also be influenced by geometric
and electronic constraints imposed by the enzyme that are not
reproduced using a simplified TS model. Previous QM/MM studies
of COMT have shown that increasing the number of atoms in-
cluded in the QM region impacts the predicted donor–acceptor
geometry in the bound complex of COMT, SAM, and catechol (42).
Thus, it is possible that including atoms from amino acids from
NSD2 active-site residues in our QM calculation will influence the
predicted KIEs. Here, we included the backbone carbonyls of
R1138 and F1117 and side chain of Y1179, whose positions are
conserved among SET domain containing PKMT, in our TS cal-
culation (Fig. 4A) (43). The corresponding residues in SET7/9 are
proposed to interact with the hydrogen atoms on the transferring
methyl group (43, 44). Including these interactions in our model, we
observed a match to all intrinsic KIEs with d2 fixed at 2.53 Å and d1
at 2.10 Å (TS2 in Fig. 4A). The predicted Me-3H3, Me-
2H3, and 5′-3
H2 KIEs were more inverse, or less normal, than those observed for
a simplified TS model (TS1) with the same geometry, indicating the
Me-H3 and 5′-H2 bond vibrational modes are more constrained in
the presence of these active-site interactions. However, there is no
evidence that the donor–acceptor distance is compressed in our TS
model and the intrinsic KIEs for NSD2 are consistent with product-
like TS models with a shorter bond to the nucleophilic nitrogen.
The total donor–acceptor distance in this model is in good agree-
ment with previous QM/MM calculations for related PKMTs that
predict a range of possible TS geometries (21, 22, 45–48). Com-
pared with the TS geometry calculated for other human PKMTs,
the TS for NSD2 is more product-like, having a more dissociated C–
S bond. This may allow for the design of NSD2-specific inhibitors
that mimic a product-like TS geometry.
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TS Bond Order and Charge Distribution. The total bond order to
both the leaving group and nucleophile in an SN2 reaction can
vary between 0, for an extremely loose TS, or greater than 1 for
compressed TS geometry. By comparison, TS2 has calculated
bond orders of 0.382 and 0.482 for the C–S and C–N bonds,
respectively. The sum of these bond orders is consistent with a
loose donor–acceptor distance in the NSD2 TS structure. Fig. 4
highlights the electrostatic potential and natural bond orbital
(NBO) charge distribution in TS2 compared with that of SAM
and the methyltransferase inhibitor sinefungin. A positive charge
is predominantly localized on the sulfur atom of SAM in GS2, as
indicated by the NBO charge of 0.930 for the sulfur atom com-
pared with 0.024 for the Me group carbon and hydrogen. In TS2,
the positive charge on sulfur is reduced to 0.398 with a corre-
sponding increase for the Me group to 0.326, consistent with an
SN2 TS where the positive charge is distributed between the
leaving group, transferring group, and nucleophile. The same
distribution is observed for the electrostatic potential (Fig. 4C),
where a positive electrostatic potential is localized on sulfur in
SAM and distributed between the sulfur, methyl carbon, and
lysine nitrogen in TS2. Analogs of sinefungin have been reported
as selective inhibitors of SETD2 and proposed to mimic the TS
of this enzyme (49). However, the electrostatic potential distri-
bution for sinefungin appears to more closely mimic the charge
localization of SAM than our TS2 (Fig. 4C). It is likely that
chemically stable analogs of the NSD2 TS will require that a
positive charge be distributed between at least two atoms and
located at least 2.5 Å from a neutral atom mimicking the leaving
group sulfur. Work is currently underway to design such analogs.
Conclusions
NSD2 predominantly catalyzes the dimethylation of HeLaNuc on
H3K36 in vitro, consistent with the activity of full-length NSD2
(11, 17). Using a combination of experimental KIE measurements
and density functional theory calculations, we have determined a
TS structure for the NSD2 SET domain-catalyzed methylation of
histone H3K36. The intrinsic KIEs are consistent with an SN2
reaction mechanism where methyl group transfer is significantly
rate limiting. All of the intrinsic KIEs are consistent with a
product-like TS geometry with a longer leaving group distance and
shorter nucleophile distances of 2.53 and 2.10 Å, respectively. A
comparison of electrostatic potential for the predicted TS struc-
ture and SAM GS indicate the positive charge on SAM is dis-
tributed between the leaving-group sulfur, the transferring methyl
group, and the nitrogen nucleophile at the TS. This geometry and
charge distribution can now guide future TS analog design for
inhibitors of NSD2. Although a single TS structure for the NSD2-
catalyzed monomethylation of H3K36 was sufficient to match the
observed KIEs for the methylation of HeLaNuc, it is possible that
the individual monomethylation and dimethylation reactions
would produce different KIEs and TS structures. To address
this, KIE studies using chemically defined nucleosome sub-
strates that are either unmethylated or monomethylated at H3K36
are currently underway.
Materials and Methods
Materials. L-[Me-14C]Methionine and L-[Me-3H3]methionine were purchased
from PerkinElmer. D-[1-3H]Ribose, D-[6-3H2]glucose, D-[6-
14C]glucose, and
[8-14C]adenine were purchased from American Radiolabeled Chemicals.
L-[Me-2H3]Methionine was purchased from Cambridge Isotope Laboratories.
Hexokinase pyruvate kinase, myokinase, phosphoriboisomerase, glucose-6-
phosphate dehydrogenase, glutamic acid dehydrogenase, and 6-phospho-
gluconic acid dehydrogenase were purchased from Sigma-Aldrich. Adenine
phosphoribosyltransferase, phosphoribosyl-α-1-pyrophosphate synthetase,
and ribokinase and SAM synthetase (SAMsyn) were prepared as previously
described (50–52). HeLaNucs were extracted and purified as primarily mon-
onucleosome and dinucleosome from cultured HeLa cells as previously de-
scribed (53). Other chemicals and reagents were obtained from commercial
sources and used without further purification. Human NSD2 SET domain
(amino acid residues 980–1365) was expressed recombinantly and purified
as described in SI Materials and Methods, and contained no bound SAM or
S-adenosyl-L-homocysteine (SAH).
Methylation of HeLaNuc. NSD2 reaction mixtures containing 1 μM HeLaNuc,
100 nM NSD2, and 20 μM [Me-2H3]SAM in 50 mM Tris·HCl (pH 9.0) with 5 mM
MgCl2, 30 mM NaCl, 4 mM DTT, and 5% (mass/vol) glycerol were moni-
tored by LC-MS to track newly installed methyl marks as described in SI
Materials and Methods.
Synthesis of Isotope-Labeled SAM. 1′-3H–, 5′-3H2–, and 5′-14C–labeled ATPs
were prepared as described previously (50). [8-14C]ATP was synthesized
enzymatically in an analogous manner using 8-14C–labeled adenine (Fig. S1).
[36S]Methionine was prepared chemoenzymatically from 36S-sulfur as pre-
viously described (54). 1′-3H–, 5′-3H2–, 5′-14C–, 8-14C–, Me-3H3–, Me-14C–, Me-2H3–,
Me-2H3, 1′-3H–, and 36S, 8-14C–labeled SAM were prepared using Escherichia
coli SAMsyn from the corresponding labeled ATPs or methionines (Table S1)
as described in SI Materials and Methods.
Measurement of KIEs and Forward Commitment. KIEs on V/K were measured
using the competitive radiolabel approach (24, 50). SAM labeled at the atomic
position of interest was mixed with an appropriate remote-labeled SAM bear-
ing the light isotope at the position of interest shown in Table S2. KIEs were
calculated from the change in isotope ratio in the remaining SAM substrate
after 15–45% of the SAM substrate was consumed. Forward commitment (Cf)
was measured using the isotope-trapping method (27). Detailed methods for
the measurement of both KIEs and Cf are found in SI Materials and Methods.
Computational Methods. The TS for methyl transfer catalyzed by NSD2 was
studied by density functional theory in m062X/6-31G* as implemented in
Gaussian 09 (38). Starting coordinates for the TS were derived from an
overlay of the crystal structures of NSD1 (PDB ID code 3OOI) (34), SET7/9
(PDB ID codes 2F69 and 1XQH) (35), SET8 (PDB ID codes 3F9Y and 3F9W) (Fig. 3
and Fig. S2) (36). Initial coordinates for TS1 were located at a first-order
saddle point and expanded to include d1 of 1.8, 2.0, 2.4, and 2.6 Å and d2 of
2.0, 2.2, 2.4, and 2.6 Å (Fig. S3). The same calculations were performed to
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Fig. 4. Geometry and electrostatic potential surface of the NSD2 TS struc-
ture. (A) TS structure for H3K36 methylation catalyzed by NSD2 with active-
site amino acids F1117, M1140, and Y1179 (TS2). (B) Electrostatic potential
surface map (EPSM) for TS2 (red, partial negative; blue, partial positive). (C) A
comparison of the EPSM for TS2, SAM, and methyltransferase inhibitor sine-
fungin. The NBO charge for the sulfur atom, CH3 group (sum of carbon and
hydrogen), and lysine NH2 group are shown in parentheses for TS2 and SAM.
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locate the TS for the second methylation reaction (Fig. S4). Coordinates for
the low energy conformation of SAM in the PubChem 3D database was used
for the SAM ground states (GS) (55). SAM GS conformations were calculated
at the same level of theory including water as an implicit solvent. The GS
were located at local minima and contained no imaginary frequencies. A
final TS model, including 40 atoms from active-site residues derived from the
crystal structure of NSD1 (3OOI) (34), was calculated at the m062X/6-31Gd*
level of theory (TS2). These residues are conserved between NSD1 and NSD2.
TS2 contains a single imaginary frequency corresponding to the methyl
group transfer. KIEs for each TS structure were calculated from the scaled
vibrational frequencies using ISOEFF98 with the appropriate GS structures.
Coordinates for all TS models are available upon request.
NBO analysis was performed for TS2 and the SAM (Fig. 4) using the same
level of theory. Electrostatic potential maps for TS2 and bound SAM were
visualized in Gaussview 5.0 using potential and density cubes generated
from the NBO calculations (isovalue, 0.04).
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